Candidate serum markers in newly diagnosed Crohn's disease patients

被引：0
|
作者：
Smids, C. [1 ]
Horje, C. Horjus Talabur [1 ]
Nierkens, S. [2 ,3 ]
Drylewicz, J. [4 ]
Groenen, M. [1 ]
Wahab, P. [1 ]
van Lochem, E. [5 ]
机构：
[1] Rijnstate Hosp, IBD Ctr, Gastroenterol & Hepatol, Arnhem, Netherlands
[2] Univ Med Ctr Utrecht, U DAIR, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands
[5] Rijnstate Hosp, Microbiol & Immunol, Arnhem, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P267
引用
收藏
页码：S212 / S223
页数：2
相关论文
共 50 条
  • [1] Serum amyloid A for predicting prognosis in patients with newly diagnosed Crohn's disease
    Chen, Qia
    Zhang, Xi
    Tie, Yizhe
    Zhang, Jianwu
    Huang, Pinwei
    Xie, Yuxuan
    Zhang, Liqian
    Tang, Xueer
    Zeng, Zhirong
    Li, Li
    Chen, Minhu
    Chen, Rirong
    Zhang, Shenghong
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [2] Serum Amyloid A for Predicting Surgery and Disease Exacerbation in Patients with Newly Diagnosed Crohn's Disease
    Chen, R.
    Chen, Q.
    Chen, M.
    Zhang, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I909 - I909
  • [3] Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course
    Smids, Carolijn
    Horje, Carmen S. Horjus Talabur
    Nierkens, Stefan
    Drylewicz, Julia
    Groenen, Marcel J. M.
    Wahab, Peter J.
    van Lochem, Ellen G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1090 - 1100
  • [4] Early Disease Progression in Patients with newly diagnosed Crohn's Disease
    Stallmach, A.
    Bokemeyer, B.
    Teich, N.
    Schmidt, C.
    INTERNIST, 2013, 54 : 24 - 24
  • [5] A changing trend in the management of patients with newly diagnosed Crohn’s disease
    A. Qasim
    N. Ullah
    P. Crotty
    N. Swan
    N. Breslin
    B. Ryan
    W. Torreggiani
    E. Eguare
    P. Neary
    H. O’Connor
    C. O’Morain
    Irish Journal of Medical Science, 2011, 180 : 643 - 647
  • [6] Therapeutic Decision Making in Newly Diagnosed Crohn's Disease Patients
    Nuij, Veerle J.
    Baars, Judith E.
    Ruiners, Ernst J.
    van der Woude, Christien J.
    GASTROENTEROLOGY, 2011, 140 (05) : S278 - S278
  • [7] Rifaximin monotherapy was effective in patients with newly diagnosed Crohn's disease
    Shafran, Ira
    Burgunder, P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S237 - S237
  • [8] A changing trend in the management of patients with newly diagnosed Crohn's disease
    Qasim, A.
    Ullah, N.
    Crotty, P.
    Swan, N.
    Breslin, N.
    Ryan, B.
    Torreggiani, W.
    Eguare, E.
    Neary, P.
    O'Connor, H.
    O'Morain, C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 (03) : 643 - 647
  • [9] Rifaximin for the treatment of newly diagnosed Crohn's disease
    Shafran, Ira
    Burgunder, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S395 - S396
  • [10] A watchful approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype
    Yassin, S.
    Fliss-Isakov, N.
    Ron, Y.
    Hirsch, A.
    Cohen, N. A.
    Maharshak, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S633 - S633
12345